| Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial AC Keech, P Mitchell, PA Summanen, J O'Day, TME Davis, MS Moffitt, ... The Lancet 370 (9600), 1687-1697, 2007 | 1375 | 2007 |
| Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ... The Lancet 393 (10170), 407-415, 2019 | 673 | 2019 |
| Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study TME Davis, R Ting, JD Best, MW Donoghoe, PL Drury, DR Sullivan, ... Diabetologia 54, 280-290, 2011 | 374 | 2011 |
| TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an … T Leong, BM Smithers, K Haustermans, M Michael, V Gebski, D Miller, ... Annals of surgical oncology 24, 2252-2258, 2017 | 253 | 2017 |
| Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence PN Butow, J Turner, J Gilchrist, L Sharpe, AB Smith, JE Fardell, S Tesson, ... Journal of Clinical Oncology 35 (36), 4066-4077, 2017 | 189 | 2017 |
| Cholesterol Treatment Trialists’(CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants … J Fulcher, R O’connell, M Voysey, J Emberson, L Blackwell, B Mihaylova, ... Lancet 385 (9976), 1397-1405, 2015 | 176 | 2015 |
| Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ... The lancet oncology 8 (7), 603-612, 2007 | 165 | 2007 |
| Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study FJ Moloney, P Guitera, E Coates, NK Haass, K Ho, R Khoury, ... JAMA dermatology 150 (8), 819-827, 2014 | 150 | 2014 |
| Single index of multimorbidity did not predict multiple outcomes JE Byles, C D'Este, L Parkinson, R O'Connell, C Treloar Journal of clinical epidemiology 58 (10), 997-1005, 2005 | 140 | 2005 |
| Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials C Reith, C Baigent, L Blackwell, J Emberson, E Spata, K Davies, H Halls, ... The Lancet 400 (10355), 832-845, 2022 | 120 | 2022 |
| The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality RE Neale, C Baxter, BD Romero, DSA McLeod, DR English, ... The Lancet Diabetes & Endocrinology 10 (2), 120-128, 2022 | 108 | 2022 |
| Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales A Linton, N Pavlakis, R O'connell, M Soeberg, S Kao, S Clarke, J Vardy, ... British journal of cancer 111 (9), 1860-1869, 2014 | 101 | 2014 |
| The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study KL Ong, AS Januszewski, R O’Connell, AJ Jenkins, A Xu, DR Sullivan, ... Diabetologia 58, 464-473, 2015 | 93 | 2015 |
| The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention MKC Ng, ASC Yong, M Ho, MG Shah, C Chawantanpipat, R O’Connell, ... Circulation: Cardiovascular Interventions 5 (4), 515-522, 2012 | 90 | 2012 |
| Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes KL Ong, KA Rye, R O'Connell, AJ Jenkins, C Brown, A Xu, DR Sullivan, ... The Journal of Clinical Endocrinology & Metabolism 97 (12), 4701-4708, 2012 | 88 | 2012 |
| Randomised controlled trial of health assessments for older Australian veterans and war widows JE Byles, M Tavener, NH Higginbotham, L Francis, JE Marley, ... Medical Journal of Australia 181 (4), 186-190, 2004 | 85 | 2004 |
| Fenofibrate Intervention and Event Lowering in Diabetes Study investigators. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate … TM Davis, R Ting, JD Best, MW Donoghoe, PL Drury, DR Sullivan, ... Diabetologia 54 (2), 280-290, 2011 | 81 | 2011 |
| Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes RL O’Connell, LLY Lim Methods of information in medicine 39 (01), 7-11, 2000 | 75 | 2000 |
| Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study GJ Hankey, NE Anderson, RD Ting, AS Veillard, M Romo, M Wosik, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (3), 281-287, 2013 | 74 | 2013 |
| HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes B Waldman, AJ Jenkins, TME Davis, MR Taskinen, R Scott, RL O’Connell, ... Diabetes care 37 (8), 2351-2358, 2014 | 72 | 2014 |
